V. O. Generalov
Research Subjects
V. O. Generalov has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Tatiana Obodzinskaya
Clinic “PlanetaMed
10 shared publications - Angelina N. Aleksandrenkova
Clinic “PlanetaMed
9 shared publications - G. V. Larionov
Medical Center “PlanetaMed
8 shared publications - Tatiana P. Klyushnik
Medline LLC
6 shared publications - Тимур Русланович Садыков
Medical Center “PlanetaMed
5 shared publications - Maria A. Omelchenko
Central State Medical Academy of the Presidential Administration of the Russian Federation
4 shared publications
Latest Publications
- 16 November 2026
- Published by Arterialnaya Gipertenziya in Translational Medicine
- Vol. 13 (5)
Urinary organic acid metabolic patterns in children with autism spectrum disorder
Background. Autism spectrum disorder (ASD) is characterized by substantial biological heterogeneity, with disturbances in energy metabolism and mitochondrial function considered among the potential mechanisms involved in its pathogenesis. Urinary organic acid analysis provides an indirect assessment of interconnected metabolic pathways, although interpretation of individual metabolites is limited by their functional overlap. Therefore, a domain-oriented approach may be useful for evaluating integrated metabolic patterns in children with ASD. Objective. To conduct a comparative analysis of the metabolic domains of urinary organic acids and their combinations (patterns) associated with energy metabolism and mitochondrial function in children with ASD and typically developing children. Materials and Methods. In a single-center observational cross-sectional study, 200 children were examined: 105 with ASD (3–9 years) and 95 typically developing controls. Twenty-eight urinary organic acids were quantified by gas chromatography-mass spectrometry. Metabolites were grouped into four functional domains: carbohydrate, lipid, amino acid and tricarboxylic acid (TCA) cycle. Principal component analysis, logistic regression and ROC analysis were used to derive integral domain indices; between-group differences were assessed by Mann–Whitney U and χ 2 tests. Results. The amino acid domain (AUC = 0.923) and the TCA domain (AUC=0.868) showed the highest diagnostic performance, with abnormalities detected in 87.6 % and 80.0 % of ASD cases versus 12.6 % and 20.0 % in controls. Carbohydrate and lipid domains demonstrated moderate diagnostic value. ASD patients primarily exhibited combined patterns involving three or more domains, indicating widespread mitochondrial metabolic involvement. Conclusion. Domain-oriented analysis of urinary organic acids may provide a basis for metabolic stratification and personalized energy-targeted corrections.
- 16 November 2026
- Published by Arterialnaya Gipertenziya in Translational Medicine
- Vol. 13 (5)
Urinary organic acid metabolic patterns in children with autism spectrum disorder
Background. Autism spectrum disorder (ASD) is characterized by substantial biological heterogeneity, with disturbances in energy metabolism and mitochondrial function considered among the potential mechanisms involved in its pathogenesis. Urinary organic acid analysis provides an indirect assessment of interconnected metabolic pathways, although interpretation of individual metabolites is limited by their functional overlap. Therefore, a domain-oriented approach may be useful for evaluating integrated metabolic patterns in children with ASD. Objective. To conduct a comparative analysis of the metabolic domains of urinary organic acids and their combinations (patterns) associated with energy metabolism and mitochondrial function in children with ASD and typically developing children. Materials and Methods. In a single-center observational cross-sectional study, 200 children were examined: 105 with ASD (3–9 years) and 95 typically developing controls. Twenty-eight urinary organic acids were quantified by gas chromatography-mass spectrometry. Metabolites were grouped into four functional domains: carbohydrate, lipid, amino acid and tricarboxylic acid (TCA) cycle. Principal component analysis, logistic regression and ROC analysis were used to derive integral domain indices; between-group differences were assessed by Mann–Whitney U and χ 2 tests. Results. The amino acid domain (AUC = 0.923) and the TCA domain (AUC=0.868) showed the highest diagnostic performance, with abnormalities detected in 87.6 % and 80.0 % of ASD cases versus 12.6 % and 20.0 % in controls. Carbohydrate and lipid domains demonstrated moderate diagnostic value. ASD patients primarily exhibited combined patterns involving three or more domains, indicating widespread mitochondrial metabolic involvement. Conclusion. Domain-oriented analysis of urinary organic acids may provide a basis for metabolic stratification and personalized energy-targeted corrections.
- Open Access
- 6 October 2026
- Published by FSBEI of Higher Education SamSMU of Ministry of Health of the Russian Federation in Science and Innovations in Medicine
- Vol. 11 (4) , 282-286
Gut microbiota and adolescent depression
This paper dwells on the connection between gut microbiota and depression in adolescents, along with a case report of a 15-year-old patient with a mild depressive episode who was treated primarily by targeting the gut microbiota. This therapeutic approach is pathogenetically justified by the specific nature of adolescent depression, in which the elevated reactivity of the limbic system plays a significant role. Given the limbic system’s high sensitivity to signals from the hypothalamic-pituitary-adrenal (HPA) axis, reducing HPA axis hyperactivity is a key component of therapy. The most accessible target for mitigating the negative impact of stress on HPA axis function, within the “microbiota-gut-brain” axis, is the initial link in the chain: the microbiota itself. Consequently, the use of probiotic agents, which offer both a favorable safety profile and proven efficacy, holds promise for the treatment and prevention of adolescent depression.
- 6 October 2026
- Published by FSBEI of Higher Education SamSMU of Ministry of Health of the Russian Federation in Science and Innovations in Medicine
- Vol. 11 (4) , 282-286
Open AccessGut microbiota and adolescent depression
This paper dwells on the connection between gut microbiota and depression in adolescents, along with a case report of a 15-year-old patient with a mild depressive episode who was treated primarily by targeting the gut microbiota. This therapeutic approach is pathogenetically justified by the specific nature of adolescent depression, in which the elevated reactivity of the limbic system plays a significant role. Given the limbic system’s high sensitivity to signals from the hypothalamic-pituitary-adrenal (HPA) axis, reducing HPA axis hyperactivity is a key component of therapy. The most accessible target for mitigating the negative impact of stress on HPA axis function, within the “microbiota-gut-brain” axis, is the initial link in the chain: the microbiota itself. Consequently, the use of probiotic agents, which offer both a favorable safety profile and proven efficacy, holds promise for the treatment and prevention of adolescent depression.
- 7 August 2026
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 126 (7) , 115-122
Quality of life of parents of children with autism spectrum disorders
Objective. To establish a correlation between the severity of clinical symptoms in children diagnosed with autism spectrum disorders (ASDs) and the quality of life experienced by their parents, and identify potential targets for effective interventions in care. Material and methods. The study included a sample of 40 parents of children diagnosed with ASD and 37 parents of neurotypical children. The clinical and psychometric evaluation of the children with ASD was conducted using the Childhood Autism Rating Scale (CARS). Additionally, the Quality of Life in Autism Questionnaire (QoLA) was used to assess parents’ quality of life. Statistical analyses were performed using MS Excel and STATISTICA software, employing nonparametric methods. Results. The psychometric assessment using the CARS scale yielded an average score of 22.6±5.8 for the examined children, indicating a mild autism classification. The total QoLA score for parents of children with ASD was 132.6±25.8 points, compared with 171.8±23.6 points for parents of neurotypical children (p<0.001). The quality of life of parents, as assessed by Part B of the QoLA scale, was found to be correlated with the severity of ASD as measured by the CARS scale (p<0.05). The primary symptoms identified that negatively impacted the quality of life of parents included the social impairments associated with autism, challenges in collaborative engagement, a lack of comprehension regarding social rules and roles, alongside communication disorders (p<0.05). Conclusions. The findings highlight potential targets for social and therapeutic interventions with families, which may alleviate parental distress and enhance the quality of life for parents of children diagnosed with ASD.
- 7 August 2026
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 126 (7) , 115-122
Quality of life of parents of children with autism spectrum disorders
Objective. To establish a correlation between the severity of clinical symptoms in children diagnosed with autism spectrum disorders (ASDs) and the quality of life experienced by their parents, and identify potential targets for effective interventions in care. Material and methods. The study included a sample of 40 parents of children diagnosed with ASD and 37 parents of neurotypical children. The clinical and psychometric evaluation of the children with ASD was conducted using the Childhood Autism Rating Scale (CARS). Additionally, the Quality of Life in Autism Questionnaire (QoLA) was used to assess parents’ quality of life. Statistical analyses were performed using MS Excel and STATISTICA software, employing nonparametric methods. Results. The psychometric assessment using the CARS scale yielded an average score of 22.6±5.8 for the examined children, indicating a mild autism classification. The total QoLA score for parents of children with ASD was 132.6±25.8 points, compared with 171.8±23.6 points for parents of neurotypical children (p<0.001). The quality of life of parents, as assessed by Part B of the QoLA scale, was found to be correlated with the severity of ASD as measured by the CARS scale (p<0.05). The primary symptoms identified that negatively impacted the quality of life of parents included the social impairments associated with autism, challenges in collaborative engagement, a lack of comprehension regarding social rules and roles, alongside communication disorders (p<0.05). Conclusions. The findings highlight potential targets for social and therapeutic interventions with families, which may alleviate parental distress and enhance the quality of life for parents of children diagnosed with ASD.
- 29 January 2026
- Published by Federal Center for Hygiene and Epidemiology in ЗДОРОВЬЕ НАСЕЛЕНИЯ И СРЕДА ОБИТАНИЯ - ЗНиСО / PUBLIC HEALTH AND LIFE ENVIRONMENT
- Vol. 34 (1) , 66-78
The Role of Dietary Factors in Prevention of Age-Related Cognitive Impairment: A Descriptive Literature Review
Introduction: No effective pharmaceutical treatment for age-related cognitive impairment and dementia is available nowadays, so prevention plays a key role. Objective: To summarize published data on the influence of various dietary factors on cognitive functions and associated pathological processes. Materials and Methods: We searched for publications on the topic issued over the previous 36 years in the MEDLINE and Google Scholar electronic databases, selected 72 studies containing an empirical assessment of the role of nutritional factors in preventing age-related cognitive disorders, and performed their descriptive analysis. Results: Excessive intake of added and refined sugars is associated with impaired cognitive performance; increased intake of omega-3 polyunsaturated fatty acids is associated with a lower risk of age-related cognitive decline while saturated fats pose a higher risk. High protein intake has been shown to correlate with better cognitive outcomes. Tyrosine and tryptophan have a positive effect on memory and reaction time so their high intake mitigates the risks of cognitive decline and Alzheimer’s disease by reducing oxidative stress. Vitamin D deficiency is linked to an increased risk of cognitive impairments. Adequate polyphenol intake demonstrates neuroprotective, neuroplastic, and anti-inflammatory effects. Dietary adherence determines cognitive outcomes: commitment to the Mediterranean diet is associated with a lower risk of mild cognitive impairment and Alzheimer’s disease. The Mediterranean-DASH Diet Intervention for Neurodegenerative Delay was developed by scientists to reduce the risk of cognitive impairments, as well as to slow brain aging and prevent Alzheimer’s disease. The ketogenic/low-carbohydrate diet improves memory. The Western-style diet is associated with accelerated cognitive decline and an increased risk of dementia; it enhances inflammation and vascular-metabolic risk factors. Conclusions: Most studies suggest potential benefits of consuming certain micronutrients for cognitive health and lower risks of age-related cognitive disorders in different groups of population. Changes in modifiable lifestyle factors and, above all, nutrition are key strategies for maintaining brain health in aging.
- 29 January 2026
- Published by Federal Center for Hygiene and Epidemiology in ЗДОРОВЬЕ НАСЕЛЕНИЯ И СРЕДА ОБИТАНИЯ - ЗНиСО / PUBLIC HEALTH AND LIFE ENVIRONMENT
- Vol. 34 (1) , 66-78
The Role of Dietary Factors in Prevention of Age-Related Cognitive Impairment: A Descriptive Literature Review
Introduction: No effective pharmaceutical treatment for age-related cognitive impairment and dementia is available nowadays, so prevention plays a key role. Objective: To summarize published data on the influence of various dietary factors on cognitive functions and associated pathological processes. Materials and Methods: We searched for publications on the topic issued over the previous 36 years in the MEDLINE and Google Scholar electronic databases, selected 72 studies containing an empirical assessment of the role of nutritional factors in preventing age-related cognitive disorders, and performed their descriptive analysis. Results: Excessive intake of added and refined sugars is associated with impaired cognitive performance; increased intake of omega-3 polyunsaturated fatty acids is associated with a lower risk of age-related cognitive decline while saturated fats pose a higher risk. High protein intake has been shown to correlate with better cognitive outcomes. Tyrosine and tryptophan have a positive effect on memory and reaction time so their high intake mitigates the risks of cognitive decline and Alzheimer’s disease by reducing oxidative stress. Vitamin D deficiency is linked to an increased risk of cognitive impairments. Adequate polyphenol intake demonstrates neuroprotective, neuroplastic, and anti-inflammatory effects. Dietary adherence determines cognitive outcomes: commitment to the Mediterranean diet is associated with a lower risk of mild cognitive impairment and Alzheimer’s disease. The Mediterranean-DASH Diet Intervention for Neurodegenerative Delay was developed by scientists to reduce the risk of cognitive impairments, as well as to slow brain aging and prevent Alzheimer’s disease. The ketogenic/low-carbohydrate diet improves memory. The Western-style diet is associated with accelerated cognitive decline and an increased risk of dementia; it enhances inflammation and vascular-metabolic risk factors. Conclusions: Most studies suggest potential benefits of consuming certain micronutrients for cognitive health and lower risks of age-related cognitive disorders in different groups of population. Changes in modifiable lifestyle factors and, above all, nutrition are key strategies for maintaining brain health in aging.
- 21 November 2025
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 125 (10) , 5-11
Neurobiological basis of suicidal behavior in adolescents
Studying the biological foundations of suicidal behavior (SB) is relevant due to its contradiction of the fundamental physiological survival and self-preservation instincts. It is of particular importance in adolescents since in this age group, the prevalence of SB increases sharply. It emphasizes the need to search for reliable SB biomarkers for a valid assessment of suicidal risk and the development of preventive measures. This review presents the findings of modern biological research in the primary areas of genetics, neurochemistry, neuroimmunology, and neuroimaging, focusing on the most significant disorders associated with SB. A comprehensive study of anomalies in all the above areas helps identify a combination of the most significant ones. Additionally, understanding the various pathogenic pathways of SB development will contribute to the development of new and practical approaches to their prevention.
- 21 November 2025
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 125 (10) , 5-11
Neurobiological basis of suicidal behavior in adolescents
Studying the biological foundations of suicidal behavior (SB) is relevant due to its contradiction of the fundamental physiological survival and self-preservation instincts. It is of particular importance in adolescents since in this age group, the prevalence of SB increases sharply. It emphasizes the need to search for reliable SB biomarkers for a valid assessment of suicidal risk and the development of preventive measures. This review presents the findings of modern biological research in the primary areas of genetics, neurochemistry, neuroimmunology, and neuroimaging, focusing on the most significant disorders associated with SB. A comprehensive study of anomalies in all the above areas helps identify a combination of the most significant ones. Additionally, understanding the various pathogenic pathways of SB development will contribute to the development of new and practical approaches to their prevention.
- Open Access
- 18 September 2025
- Published by Research Institute for Healthcare Organization and Medical Management in City Healthcare
- Vol. 6 (3) , 73-86
Personalized Biomedical Intervention and Rehabilitation of Autism Spectrum Disorder Patients
Background. Modern scientific research have identified the most important biological components and pathological processes that contribute to the causes and development of an autistic specter disorder (ASD). However, autism management using psychological and pedagogical methods are of greater importance rather than medical examination and treatment. The purpose of the present study was to analyze the dynamics of ASD-related psychoneurological and laboratory indicators during the treatment using biomedical technologies. Materials and methods. The study included 68 children with moderate and severe ASD. In this work, psychopathological, psychometric, clinical, laboratory and statistical methods were used. Results revealed a pro-inflammatory state, heterogeneous changes in metabolic status, endocrine dysfunction with various degrees of impairment compensation. Personalized biomedical intervention helps to reduce the severity of psychoneurological symptoms and improve physical well-being, which is confirmed by laboratory tests. Conclusion. Interventions aimed at eliminating inner factors contributing to homeostasis disorders such as inflammation, metabolic dysfunction and hormonal imbalance contribute to the age- and gender-specific innate behavioral patterns, which results in successful outcomes in terms of normal child development. Keywords: autism spectrum disorder; neuroinflammation; metabolic dysfunction; hormonal imbalance; behavioral patterns; rehabilitation
- 18 September 2025
- Published by Research Institute for Healthcare Organization and Medical Management in City Healthcare
- Vol. 6 (3) , 73-86
Open AccessPersonalized Biomedical Intervention and Rehabilitation of Autism Spectrum Disorder Patients
Background. Modern scientific research have identified the most important biological components and pathological processes that contribute to the causes and development of an autistic specter disorder (ASD). However, autism management using psychological and pedagogical methods are of greater importance rather than medical examination and treatment. The purpose of the present study was to analyze the dynamics of ASD-related psychoneurological and laboratory indicators during the treatment using biomedical technologies. Materials and methods. The study included 68 children with moderate and severe ASD. In this work, psychopathological, psychometric, clinical, laboratory and statistical methods were used. Results revealed a pro-inflammatory state, heterogeneous changes in metabolic status, endocrine dysfunction with various degrees of impairment compensation. Personalized biomedical intervention helps to reduce the severity of psychoneurological symptoms and improve physical well-being, which is confirmed by laboratory tests. Conclusion. Interventions aimed at eliminating inner factors contributing to homeostasis disorders such as inflammation, metabolic dysfunction and hormonal imbalance contribute to the age- and gender-specific innate behavioral patterns, which results in successful outcomes in terms of normal child development. Keywords: autism spectrum disorder; neuroinflammation; metabolic dysfunction; hormonal imbalance; behavioral patterns; rehabilitation
- 29 August 2025
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 125 (8) , 35-42
Suicidal behavior in adolescents
The review addresses an urgent problem of suicide in adolescents. The prevalence of suicidal behavior in adolescents worldwide and In Russia is analyzed, and its main causes are identified. It is believed that the basis for suicidal activity is primarily psychopathological disorders, both as part of established psychiatric diseases and at the prodromal stage of mental disorders, when the first transient and nonspecific symptoms appear. When triggered by external causes, such a pathological basis easily leads to the adolescent’s suicidal readiness, which explains the common discrepancy between the insignificance of provoking factors and the severity of the consequences of suicidal activity. It determines the need for early recognition of the first symptoms of future mental illness and the establishment of their role in the development of suicidal behavior in adolescents.
- 29 August 2025
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 125 (8) , 35-42
Suicidal behavior in adolescents
The review addresses an urgent problem of suicide in adolescents. The prevalence of suicidal behavior in adolescents worldwide and In Russia is analyzed, and its main causes are identified. It is believed that the basis for suicidal activity is primarily psychopathological disorders, both as part of established psychiatric diseases and at the prodromal stage of mental disorders, when the first transient and nonspecific symptoms appear. When triggered by external causes, such a pathological basis easily leads to the adolescent’s suicidal readiness, which explains the common discrepancy between the insignificance of provoking factors and the severity of the consequences of suicidal activity. It determines the need for early recognition of the first symptoms of future mental illness and the establishment of their role in the development of suicidal behavior in adolescents.
- 29 August 2025
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 125 (8) , 7-15
Factors supporting chronic inflammation in mental illness
The presented literature review addresses factors and mechanisms of their influence on chronic inflammation throughout life, aggravating the severity of mental illness and contributing to its progression. Such factors include infections, intestinal microbiome disorders, lack of physical activity, overweight, chronic stress, and metabolic imbalance. Targeting these factors, in addition to standard drug therapy, can contribute to a mild course of the disease, improve the quality and duration of remissions, and, in some cases, overcome resistance to therapy.
- 29 August 2025
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 125 (8) , 7-15
Factors supporting chronic inflammation in mental illness
The presented literature review addresses factors and mechanisms of their influence on chronic inflammation throughout life, aggravating the severity of mental illness and contributing to its progression. Such factors include infections, intestinal microbiome disorders, lack of physical activity, overweight, chronic stress, and metabolic imbalance. Targeting these factors, in addition to standard drug therapy, can contribute to a mild course of the disease, improve the quality and duration of remissions, and, in some cases, overcome resistance to therapy.
- Open Access
- 24 September 2024
- Published by Research Institute for Healthcare Organization and Medical Management in City Healthcare
- Vol. 5 (3) , 47–56
Functional Recovery in Severe Genetic Syndromes: Clinical Experience of Cell Therapy in Angelman Syndrome
Genetic pathologies remain a major challenge in modern medicine, although medical technologies, laboratory diagnostics, and targeted therapy tools have significantly developed and expanded. Since etiopathogenetic therapy is not provided, children with genetic disorders receive only symptomatic treatment stabilizing their status and mitigating life-threatening factors, but not contributing to even a partially functional recovery of damaged organs. Angelman syndrome is a rare and severe genetic pathology characterized by delayed psychomotor development, seizures, and conduct disorders. Patients with this diagnosis have, in general, a poor prognosis for development and socialization. Stem cell transplantation is a promising approach to treating various genetic, neurodegenerative, and autoimmune diseases. The article describes two clinical cases of patients with verified Angelman syndrome who received a combination therapy with stem cell transplantation as a key method. Health outcomes were analyzed using the data of physical examination, assessment of neurological and psychological statuses, testing methods of neuroimaging and functional medicine, and laboratory testing of hormonal, mitochondrial, immune states of patients. The results showed a significant improvement in patients’ psychomotor development and a positive dynamic in laboratory and functional indicators. Therefore, the studied combination therapy approach could become a promising method for treating patients with severe genetic diseases accompanied by serious nervous system damage.
- 24 September 2024
- Published by Research Institute for Healthcare Organization and Medical Management in City Healthcare
- Vol. 5 (3) , 47–56
Open AccessFunctional Recovery in Severe Genetic Syndromes: Clinical Experience of Cell Therapy in Angelman Syndrome
Genetic pathologies remain a major challenge in modern medicine, although medical technologies, laboratory diagnostics, and targeted therapy tools have significantly developed and expanded. Since etiopathogenetic therapy is not provided, children with genetic disorders receive only symptomatic treatment stabilizing their status and mitigating life-threatening factors, but not contributing to even a partially functional recovery of damaged organs. Angelman syndrome is a rare and severe genetic pathology characterized by delayed psychomotor development, seizures, and conduct disorders. Patients with this diagnosis have, in general, a poor prognosis for development and socialization. Stem cell transplantation is a promising approach to treating various genetic, neurodegenerative, and autoimmune diseases. The article describes two clinical cases of patients with verified Angelman syndrome who received a combination therapy with stem cell transplantation as a key method. Health outcomes were analyzed using the data of physical examination, assessment of neurological and psychological statuses, testing methods of neuroimaging and functional medicine, and laboratory testing of hormonal, mitochondrial, immune states of patients. The results showed a significant improvement in patients’ psychomotor development and a positive dynamic in laboratory and functional indicators. Therefore, the studied combination therapy approach could become a promising method for treating patients with severe genetic diseases accompanied by serious nervous system damage.
- Open Access
- 18 June 2024
- Published by Research Institute for Healthcare Organization and Medical Management in City Healthcare
- Vol. 5 (2) , 16-23
Ketogenic Diet for Type I Diabetes Mellitus. Literature Review and Clinical Experience
To date, treating type I diabetes mellitus (T1D) is a difficult clinical task that is based, from the traditional point of view, exclusively on adjusting an insulin dose and monitoring a daily carbohydrate intake. Dietary changes are not considered a type of treatment in T1D patients yet, although this autoimmune disease is accompanied by disorders of carbohydrate metabolism. The article explores the international experience in the use of a low-carbohydrate diet and the features of disease development when putting patients into ketosis on a ketogenic diet. Article discusses the clinical experience obtained during T1D patient management, including ketogenic diet and mitochondrial support, at the clinic “PlanetaMed”. In addition, the article describes the case reports and case studies. According to the clinical experience of “PlanetaMed” specialists, the use of a ketogenic diet results in a decreasing blood glucose level in almost all cases. The average dose of injected insulin was 22.8 units before the ketogenic diet and 6,625 units during the ketogenic diet. The absolute decrease was 16.205 units, and the relative decrease was 70.9%. At the same time, the concentration level of glucose decreased by 39.2%. The decrease in blood glucose level and the injected insulin dose were connected (correlation coefficient: 0.76). Therefore, the studies have shown a significant positive impact of a ketogenic diet on the treatment of T1D patients.
- 18 June 2024
- Published by Research Institute for Healthcare Organization and Medical Management in City Healthcare
- Vol. 5 (2) , 16-23
Open AccessKetogenic Diet for Type I Diabetes Mellitus. Literature Review and Clinical Experience
To date, treating type I diabetes mellitus (T1D) is a difficult clinical task that is based, from the traditional point of view, exclusively on adjusting an insulin dose and monitoring a daily carbohydrate intake. Dietary changes are not considered a type of treatment in T1D patients yet, although this autoimmune disease is accompanied by disorders of carbohydrate metabolism. The article explores the international experience in the use of a low-carbohydrate diet and the features of disease development when putting patients into ketosis on a ketogenic diet. Article discusses the clinical experience obtained during T1D patient management, including ketogenic diet and mitochondrial support, at the clinic “PlanetaMed”. In addition, the article describes the case reports and case studies. According to the clinical experience of “PlanetaMed” specialists, the use of a ketogenic diet results in a decreasing blood glucose level in almost all cases. The average dose of injected insulin was 22.8 units before the ketogenic diet and 6,625 units during the ketogenic diet. The absolute decrease was 16.205 units, and the relative decrease was 70.9%. At the same time, the concentration level of glucose decreased by 39.2%. The decrease in blood glucose level and the injected insulin dose were connected (correlation coefficient: 0.76). Therefore, the studies have shown a significant positive impact of a ketogenic diet on the treatment of T1D patients.